STOCK TITAN

Crinetics (NASDAQ: CRNX) CEO reports 1.94M share gifts and trust transfers

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Crinetics Pharmaceuticals President & CEO Richard Scott Struthers reported a series of estate and charitable planning moves involving gifts of 1,937,600 shares of common stock on May 29, 2026. The transactions are coded as bona fide gifts, with reported prices of $0.0000 per share, indicating no sale proceeds.

The gifts include transfers among multiple family trusts, a charitable remainder trust, and his spouse, with the filing noting that he disclaims beneficial ownership of certain trust-held shares except for his pecuniary interest. Following these transactions, he continues to hold significant positions, including 626,978 shares directly and 439,005 shares indirectly through Family Trust 1.

Positive

  • None.

Negative

  • None.
Insider Struthers Richard Scott
Role President & CEO
Type Security Shares Price Value
Gift Common Stock 222,200 $0.00 --
Gift Common Stock 222,200 $0.00 --
Gift Common Stock 80,000 $0.00 --
Gift Common Stock 222,200 $0.00 --
Gift Common Stock 222,200 $0.00 --
Gift Common Stock 80,000 $0.00 --
Gift Common Stock 111,100 $0.00 --
Gift Common Stock 111,100 $0.00 --
Gift Common Stock 111,100 $0.00 --
Gift Common Stock 111,100 $0.00 --
Gift Common Stock 111,100 $0.00 --
Gift Common Stock 111,100 $0.00 --
Gift Common Stock 111,100 $0.00 --
Gift Common Stock 111,100 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 439,005 shares (Indirect, By Family Trust 1); Common Stock — 626,978 shares (Direct, null)
Footnotes (1)
  1. (1) Represents gifts of shares by the Struthers Family Trust ("Family Trust 1"), of which the Reporting Person is the trustee and the Reporting Person and his spouse are beneficiaries, to (a) the Reporting Person, (b) the Reporting Person's spouse and (c) the Struthers Family Charitable Remainder Trust (the "Charitable Trust"), a charitable remainder trust of which the Reporting Person is the trustee and of which the Reporting Person and his spouse are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares held by the Charitable Trust except to the extent of his pecuniary interest therein. (2) Represents contributions of shares by the Reporting Person to (a) the GMS Dynasty Trust ("Family Trust 5") and (b) the JSS Dynasty Trust ("Family Trust 6"), each of which is an irrevocable trust with an independent trustee of which the Reporting Person's spouse and her family members, and the Reporting Person's spouse, respectively, are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares held by Family Trust 5 and Family Trust 6 except to the extent of his pecuniary interest therein. (3) Represents contributions of shares by the Reporting Person's spouse to (a) the Iowa Descendants Trust ("Family Trust 7") and (b) the RSS Dynasty Trust ("Family Trust 8"), each of which is an irrevocable trust with an independent trustee of which the Reporting Person and his family members are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares held by Family Trust 5 and Family Trust 6 except to the extent of his pecuniary interest therein.
Gifted shares 1,937,600 shares Total bona fide gifts of common stock on May 29, 2026
Gift transactions 14 transactions Number of bona fide gift entries reported
Holding entries 3 entries Non-transactional holdings disclosure lines
Direct holdings after gift 626,978 shares Common stock held directly following one gift transaction on May 29, 2026
Family Trust 1 holdings 439,005 shares Common stock held indirectly via Family Trust 1 after reported gifts
Representative gift size 222,200 shares Example size of several individual gift transfers
Charitable Trust gift 80,000 shares Gifted to the Struthers Family Charitable Remainder Trust
bona fide gift financial
"transaction_code_description: "Bona fide gift" for multiple entries"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
Charitable Remainder Trust financial
"the Struthers Family Charitable Remainder Trust (the "Charitable Trust")"
irrevocable trust financial
"each of which is an irrevocable trust with an independent trustee"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
pecuniary interest financial
"disclaims beneficial ownership ... except to the extent of his pecuniary interest"
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of the shares held by Family Trust 5 and Family Trust 6"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Struthers Richard Scott

(Last)(First)(Middle)
C/O CRINETICS PHARMACEUTICALS, INC.
6055 LUSK BOULEVARD

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Crinetics Pharmaceuticals, Inc. [ CRNX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/29/2026G(1)222,200D$0439,005IBy Family Trust 1
Common Stock05/29/2026G(1)222,200D$0216,805IBy Family Trust 1
Common Stock05/29/2026G(1)80,000D$0136,805IBy Family Trust 1
Common Stock05/29/2026G(1)222,200A$0626,978D
Common Stock05/29/2026G(1)222,200A$0223,200IBy Spouse
Common Stock05/29/2026G(1)80,000A$080,000IBy Charitable Trust
Common Stock05/29/2026G(2)111,100D$0515,878D
Common Stock05/29/2026G(2)111,100D$0404,778D
Common Stock05/29/2026G(2)111,100A$0111,100IBy Family Trust 5
Common Stock05/29/2026G(2)111,100A$0111,100IBy Family Trust 6
Common Stock05/29/2026G(3)111,100D$0112,100IBy Spouse
Common Stock05/29/2026G(3)111,100D$01,000IBy Spouse
Common Stock05/29/2026G(3)111,100A$0111,100IBy Family Trust 7
Common Stock05/29/2026G(3)111,100A$0111,100IBy Family Trust 8
Common Stock106,000IBy Family Trust 2
Common Stock110,000IBy Family Trust 3
Common Stock100,000IBy Family Trust 4
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. (1) Represents gifts of shares by the Struthers Family Trust ("Family Trust 1"), of which the Reporting Person is the trustee and the Reporting Person and his spouse are beneficiaries, to (a) the Reporting Person, (b) the Reporting Person's spouse and (c) the Struthers Family Charitable Remainder Trust (the "Charitable Trust"), a charitable remainder trust of which the Reporting Person is the trustee and of which the Reporting Person and his spouse are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares held by the Charitable Trust except to the extent of his pecuniary interest therein.
2. (2) Represents contributions of shares by the Reporting Person to (a) the GMS Dynasty Trust ("Family Trust 5") and (b) the JSS Dynasty Trust ("Family Trust 6"), each of which is an irrevocable trust with an independent trustee of which the Reporting Person's spouse and her family members, and the Reporting Person's spouse, respectively, are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares held by Family Trust 5 and Family Trust 6 except to the extent of his pecuniary interest therein.
3. (3) Represents contributions of shares by the Reporting Person's spouse to (a) the Iowa Descendants Trust ("Family Trust 7") and (b) the RSS Dynasty Trust ("Family Trust 8"), each of which is an irrevocable trust with an independent trustee of which the Reporting Person and his family members are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares held by Family Trust 5 and Family Trust 6 except to the extent of his pecuniary interest therein.
Remarks:
/s/ Tobin Schilke, as attorney-in-fact06/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Crinetics (CRNX) CEO Richard Scott Struthers report in this Form 4?

Richard Scott Struthers reported multiple bona fide gifts of Crinetics common stock. These transactions reallocated shares among family trusts, a charitable remainder trust, and his spouse, reflecting estate and charitable planning rather than open-market purchases or sales.

How many Crinetics (CRNX) shares were transferred as gifts by the CEO?

The filing shows gifts totaling 1,937,600 shares of Crinetics common stock. These shares were moved across several family-related and charitable entities on May 29, 2026, under transaction code G, which the SEC defines as a bona fide gift disposition.

Were any of the Crinetics (CRNX) CEO’s transactions open-market sales or purchases?

No, the reported transactions are all coded as G for bona fide gifts, with a transaction price of $0.0000 per share. This indicates non-market transfers, not open-market buying or selling of Crinetics stock for cash consideration.

What types of entities received the gifted Crinetics (CRNX) shares?

Recipients include multiple Struthers family dynasty trusts, the Struthers Family Charitable Remainder Trust, and the CEO’s spouse. Some trusts are described as irrevocable with independent trustees, and the CEO disclaims beneficial ownership except for any pecuniary interest.

How many Crinetics (CRNX) shares does the CEO hold after these gifts?

Post-transaction line items show continuing sizeable holdings, including 626,978 shares held directly and 439,005 shares held indirectly through Family Trust 1. Additional indirect positions remain across other family and charitable trusts listed in the filing.

Does the Crinetics (CRNX) CEO disclaim ownership of any gifted shares?

Yes. For several trusts, including the Charitable Remainder Trust and certain dynasty trusts, the CEO disclaims beneficial ownership of shares except to the extent of his pecuniary interest. This clarifies how much economic exposure he attributes to those accounts.